Telephone
61.3.9348.3333
Address
Level 2 288 Victoria Parade East Melbourne, Victoria (VIC) 3002
Description
Capitol Health Ltd. provides diagnostic imaging and related services. It provides general x-ray, magnetic resonance imaging, ultrasound, mammography, doppler, orthopantomogram, echocardiography, computer tomography, computed tomography angiography, cone beam computed tomography, nuclear medicine, bone densitomety, and fluoroscopy services. The company was founded by Andrew Duncan Harrison on December 1, 2005 and is headquartered in Docklands, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.19 - 0.32
Trade Value (12mth)
AU$133,174.00
1 week
1.59%
1 month
8.47%
YTD
39.13%
1 year
45.45%
All time high
1.11
EPS 3 yr Growth
-219.70%
EBITDA Margin
21.00%
Operating Cashflow
$36m
Free Cash Flow Return
14.40%
ROIC
-5.90%
Interest Coverage
6.30
Quick Ratio
0.40
Shares on Issue (Fully Dilluted)
1064m
HALO Sector
Healthcare
Next Company Report Date
20-Aug-25
Ex Dividend Date (est.)
20-Sep-24
Next Dividend Pay Date (est.)
21-Oct-24
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
03 September 24 |
Change in substantial shareholding from AEF
×
Change in substantial shareholding from AEF |
02 September 24 |
IDX: Proposed merger with Capitol Health Limited - Update
×
IDX: Proposed merger with Capitol Health Limited - Update |
02 September 24 |
Proposed merger with IDX - Update
×
Proposed merger with IDX - Update |
27 August 24 |
Dividend/Distribution - CAJ
×
Dividend/Distribution - CAJ |
22 August 24 |
Appendix 4E and Annual Report
×
Appendix 4E and Annual Report |
22 August 24 |
FY24 Results Release Announcement
×
FY24 Results Release Announcement |
22 August 24 |
FY24 Results Presentation
×
FY24 Results Presentation |
22 August 24 |
Final share buy-back notice
×
Final share buy-back notice |
22 August 24 |
Appendix 4G
×
Appendix 4G |
22 August 24 |
Corporate Governance Statement
×
Corporate Governance Statement |
22 August 24 |
Notification of cessation of securities - CAJ
×
Notification of cessation of securities - CAJ |
22 August 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
12 August 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
06 August 24 |
Change in substantial shareholding from AEF
×
Change in substantial shareholding from AEF |
31 July 24 |
FY24 Financial Results Release Date
×
FY24 Financial Results Release Date |
18 July 24 |
IDX: IDX & CAJ Sign Merger Implementation Deed
×
IDX: IDX & CAJ Sign Merger Implementation Deed |
18 July 24 |
CAJ enters into Merger Implementation Deed with IDX
×
CAJ enters into Merger Implementation Deed with IDX |
18 July 24 |
IDX: IDX/CAJ Merger Investor Presentation
×
IDX: IDX/CAJ Merger Investor Presentation |
18 July 24 |
Variation of MD/CEO's Employment Agreement
×
Variation of MD/CEO's Employment Agreement |
09 July 24 |
Notification regarding unquoted securities - CAJ
×
Notification regarding unquoted securities - CAJ |
02 July 24 |
Change in substantial shareholding from AEF
×
Change in substantial shareholding from AEF |
17 June 24 |
CAJ enters Process Deed following IDX's Indicative Proposal
×
CAJ enters Process Deed following IDX's Indicative Proposal |
17 June 24 |
IDX: Integral Diagnostics & Capitol Health Proposed Merger
×
IDX: Integral Diagnostics & Capitol Health Proposed Merger |
03 May 24 |
Notification of cessation of securities - CAJ
×
Notification of cessation of securities - CAJ |
24 April 24 |
Change in substantial holding from WAM/WMI/WAX
×
Change in substantial holding from WAM/WMI/WAX |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.